PRESTIGE BRAND HOLDINGS INC

NYSE: PBH (Prestige Consumer Healthcare In)

Last update: 29 Aug, 11:33AM

68.05

0.79 (1.17%)

Previous Close 67.26
Open 67.54
Volume 128,941
Avg. Volume (3M) 458,601
Market Cap 3,349,026,560
Price / Earnings (TTM) 15.97
Price / Earnings (Forward) 14.33
Price / Sales 2.90
Price / Book 1.72
52 Weeks Range
62.95 (-7%) — 90.04 (32%)
Earnings Date 6 Nov 2025
Profit Margin 18.86%
Operating Margin (TTM) 34.03%
Diluted EPS (TTM) 4.29
Quarterly Revenue Growth (YOY) 7.10%
Quarterly Earnings Growth (YOY) 1.40%
Total Debt/Equity (MRQ) 56.91%
Current Ratio (MRQ) 4.20
Operating Cash Flow (TTM) 251.52 M
Levered Free Cash Flow (TTM) 188.69 M
Return on Assets (TTM) 6.50%
Return on Equity (TTM) 12.30%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bullish Mixed
Drug Manufacturers - Specialty & Generic (Global) Bullish Mixed
Stock Prestige Consumer Healthcare In Bullish Bullish

AIStockmoo Score

1.9
Analyst Consensus 3.5
Insider Activity NA
Price Volatility 4.5
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 1.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
PBH 3 B - 15.97 1.72
CTLT 11 B - - 3.23
ZTS 71 B 0.89% 28.85 13.20
TAK 48 B 1,358.28% 65.78 1.02
HLN 47 B 1.11% 25.04 2.04
RDY 12 B 54.73% 18.38 3.07

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Core
% Held by Insiders 1.23%
% Held by Institutions 108.15%
52 Weeks Range
62.95 (-7%) — 90.04 (32%)
Median 100.00 (46.95%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Canaccord Genuity 08 Aug 2025 100.00 (46.95%) Buy 65.58

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria